A Molecular Approach to Breast Imaging

Molecular imaging is a multimodality discipline for noninvasively visualizing biologic processes at the subcellular level. Clinical applications of radionuclide-based molecular imaging for breast cancer continue to evolve. Whole-body imaging, with scintimammography and PET, and newer dedicated breast imaging systems are reviewed. The potential clinical indications and the challenges of implementing these emerging technologies are presented.

[1]  M. Plana,et al.  Magnetic resonance imaging in the preoperative assessment of patients with primary breast cancer: systematic review of diagnostic accuracy and meta-analysis , 2011, European Radiology.

[2]  R. J. Brenner.  Dedicated Dual-Head Gamma Imaging for Breast Cancer Screening in Women with Mammographically Dense Breasts: Rhodes DJ, Hruska CB, Phillips SW, et al (Mayo Clinic, Rochester, MN) Radiology 258:106-118, 2010§ , 2011 .

[3]  Dana H Whaley,et al.  Dedicated dual-head gamma imaging for breast cancer screening in women with mammographically dense breasts. , 2011, Radiology.

[4]  R. Brem,et al.  Detection of occult foci of breast cancer using breast-specific gamma imaging in women with one mammographic or clinically suspicious breast lesion. , 2010, Academic radiology.

[5]  B. Killelea,et al.  George Peters Award: How does breast-specific gamma imaging affect the management of patients with newly diagnosed breast cancer? , 2009, American journal of surgery.

[6]  Jianlun Liu,et al.  Clinical usefulness of breast-specific gamma imaging as an adjunct modality to mammography for diagnosis of breast cancer: a systemic review and meta-analysis , 2013, European Journal of Nuclear Medicine and Molecular Imaging.

[7]  Deepa Narayanan,et al.  Positron emission mammography in breast cancer presurgical planning: comparisons with magnetic resonance imaging , 2010, European Journal of Nuclear Medicine and Molecular Imaging.

[8]  Yongxue Zhang,et al.  Fluorine-18 fluorodeoxyglucose positron emission tomography-computed tomography in monitoring the response of breast cancer to neoadjuvant chemotherapy: a meta-analysis. , 2013, Clinical breast cancer.

[9]  D. Narayanan,et al.  Breast cancer: comparative effectiveness of positron emission mammography and MR imaging in presurgical planning for the ipsilateral breast. , 2011, Radiology.

[10]  M. O’Connor,et al.  Nuclear imaging of the breast: translating achievements in instrumentation into clinical use. , 2013, Medical physics.

[11]  Wendy Bruening,et al.  Noninvasive Diagnostic Tests for Breast Abnormalities: Update of a 2006 Review , 2012 .

[12]  L. Esserman,et al.  Locally advanced breast cancer: MR imaging for prediction of response to neoadjuvant chemotherapy--results from ACRIN 6657/I-SPY TRIAL. , 2012, Radiology.

[13]  Ying Yuan,et al.  Accuracy of MRI in prediction of pathologic complete remission in breast cancer after preoperative therapy: a meta-analysis. , 2010, AJR. American journal of roentgenology.

[14]  H. Xu,et al.  Tc-99m sestamibi scintimammography for the diagnosis of breast cancer: meta-analysis and meta-regression , 2011, Nuclear medicine communications.

[15]  Robert W. Maxwell,et al.  Gamma camera breast imaging lexicon. , 2012, AJR. American journal of roentgenology.

[16]  Robert W. Maxwell,et al.  The Use of Molecular Breast Imaging to Assess Response in Women Undergoing Neoadjuvant Therapy for Breast Cancer: A Pilot Study , 2012, Clinical nuclear medicine.

[17]  D. Narayanan,et al.  Breast cancer detection using high-resolution breast PET compared to whole-body PET or PET/CT , 2014, European Journal of Nuclear Medicine and Molecular Imaging.

[18]  R. Coleman,et al.  Recommendations on the Use of 18F-FDG PET in Oncology , 2008, Journal of Nuclear Medicine.

[19]  D. Narayanan,et al.  Interpretation of positron emission mammography: feature analysis and rates of malignancy. , 2011, AJR. American journal of roentgenology.

[20]  F. Sánchez,et al.  Design and evaluation of the MAMMI dedicated breast PET. , 2012, Medical physics.

[21]  W. Han,et al.  Imaging sensitivity of dedicated positron emission mammography in relation to tumor size. , 2012, Breast.

[22]  B. Kim,et al.  Usefulness of breast-specific gamma imaging as an adjunct modality in breast cancer patients with dense breast: a comparative study with MRI , 2012, Annals of Nuclear Medicine.

[23]  S. Surti.  Radionuclide methods and instrumentation for breast cancer detection and diagnosis. , 2013, Seminars in nuclear medicine.

[24]  P. Meunier,et al.  Clinical utility of breast-specific gamma imaging for evaluating disease extent in the newly diagnosed breast cancer patient. , 2009, American journal of surgery.

[25]  Paul Kinahan,et al.  Clinical Imaging Characteristics of the Positron Emission Mammography Camera: PEM Flex Solo II , 2009, Journal of Nuclear Medicine.